SPH3127 100mg: Clinical Trials

1 trial of SPH3127 100mg, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed. 1 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 11Completed 1

Follow SPH3127 100mg: new trials by email Literature Review of SPH3127 100mg trials Research Report on SPH3127 100mg

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
The Tolerability and Pharmacokinetics of Multiple Doses of SPH3127 in Chinese Healthy People
SPH3127 50mg, SPH3127 100mg, Placebo matching to SPH3127 50mg - Hypertension
Phase 1CompletedShanghai Pharmaceuticals Holding Co., Ltd242017-10-232021-11-15

Conditions studied

Hypertension (1)

Sponsors

Shanghai Pharmaceuticals Holding Co., Ltd (1)

Countries

China (1)

Results publications

PMID 33653620